Gastritis

−VE

N

16

16

%

10.5%

18.2%

+VE

N

136

72

2.827

0.093

%

89.5%

81.8%

Erosion

−VE

N

128

56

%

84.2%

63.6%

+VE

N

24

32

13.18

0.00**

%

15.8%

36.4%

Peptic ulcer

−VE

N

136

80

%

89.5%

90.9%

+VE

N

16

8

0.128

0.721

%

10.5%

9.1%

Mucosal nodularity

−VE

N

144

80

%

94.7%

90.9%

+VE

N

8

8

1.31

0.252

%

5.3%

9.1%

Chronic active gastritis

−VE

N

84

48

%

55.3%

54.5%

+VE

N

68

40

0.012

0.914

%

44.7%

45.5%

Chronic inactive gastritis

−VE

N

68

48

%

44.7%

54.5%

+VE

N

84

40

2.147

0.143

%

55.3%

45.5%

Intestinal metaplasia

−VE

N

148

84

%

97.4%

95.5%

+VE

N

4

4

0.63

0.42

%

2.6%

4.5%

Erosive gastritis

−VE

N

124

60

%

81.6%

68.2%

+VE

N

28

28

5.59

0.018*

%

18.4%

31.8%

Glandular atrophy

−VE

N

140

84

%

92.1%

95.5%

+VE

N

12

4

1.00

0.31

%

7.9%

4.5%

Reactive gastropathy

−VE

N

148

84

%

97.4%

95.5%

+VE

N

4

4

0.634

0.426

%

2.6%

4.5%

Total

N

152

88

%

100.0%

100.0%